【Shocking IPO】 The company launches a series of stem cell culture media

2023-12-05

Joint Therapeutics Co., Ltd. has accumulated 20 years of research and development experience from its core technology team both domestically and internationally. With outstanding technical capabilities and in-depth understanding of biomedical research, Pengge has recently launched a series of independently developed stem cell culture media, including Skeletal Stem Cell Medium(Mouse), Skeletal Stem Cell Medium(Human), Cartilage Stem Cell Medium(Mouse), Cartilage Stem Cell Medium(Human).


22222(1).png


The formula of this series of culture media is adopted by multiple top international laboratories. By optimizing the composition of the culture media, it can maintain the characteristics of stem cells well, conduct multiple passages of culture, and produce stem cells for scientific research and clinical trials. The work supported by this series of culture media has also been published in multiple highlevel academic papers, providing extraordinary support for bone stem cell research for biopharmaceutical enterprises and researchers. The above culture medium contains multiple specifications, please contact us for customization.


Telephone: 010-53689023

E-mail:sales@penggegroup.com

share